User login
Article Type
Changed
Thu, 12/15/2022 - 15:15
Display Headline
Anticancer Drug Aces Phase III Trial
Article PDF
Issue
Federal Practitioner - 21(2)
Topics
Page Number
13
Legacy Keywords
cancer, bortezomib, FDA, refractory multiple myelomacancer, bortezomib, FDA, refractory multiple myeloma
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 21(2)
Issue
Federal Practitioner - 21(2)
Page Number
13
Page Number
13
Topics
Article Type
Display Headline
Anticancer Drug Aces Phase III Trial
Display Headline
Anticancer Drug Aces Phase III Trial
Legacy Keywords
cancer, bortezomib, FDA, refractory multiple myelomacancer, bortezomib, FDA, refractory multiple myeloma
Legacy Keywords
cancer, bortezomib, FDA, refractory multiple myelomacancer, bortezomib, FDA, refractory multiple myeloma
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document